StockDuty ← Dashboard Nov 05, 2026 12:20 PM ET
SignalCorporate

Iovance Biotherapeutics GAAP EPS of -$0.05 beats by $0.04, revenue of $121.47M beats by $5.9M

Iovance beat EPS and revenue estimates, driven by $121.47M revenue exceeding by $5.9M.

Iovance beat EPS and revenue estimates, driven by $121.47M revenue exceeding by $5.9M.
Iovance beat EPS and revenue estimates, driven by $121.47M revenue exceeding by $5.9M. — impact context not separately stored; see What changed.
Sources